Amir London

Amir London has an extensive work experience spanning over different industries. Amir started their career as an Industrial Engineer at Rafael in 1993 and then joined Tefen as a Partner in 1995. Later, they became the General Manager at Cure Medical, Neopharm in 2005. In 2008, they transitioned to Promedico as the CEO and held this position until 2011. Amir then served as a Board Member and COO at Fidelis Diagnostics from 2011 to 2013. Amir's most recent roles include being the SVP of Business Development at Kamada from an unspecified start date in 2013 until June 2015, and subsequently becoming the CEO of Kamada in July 2015.

Amir London attended Technion - Israel Institute of Technology from 1990 to 1994. No specific degree or field of study is indicated.